Search results (1331)
« Back to PublicationsMajor Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
Roemer MGM. et al, (2018), J Clin Oncol, 36, 942 - 950
Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma From the Phase 2 CheckMate 205 Study
Cohen JB. et al, (2018), BRITISH JOURNAL OF HAEMATOLOGY, 181, 87 - 88
Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.
Morotti M. et al, (2018), Eur J Drug Metab Pharmacokinet, 43, 137 - 153
Ruxolitinib induces changes in histone modification status in patients entered into the MAJIC clinical trial
McPherson S. et al, (2018), BRITISH JOURNAL OF HAEMATOLOGY, 181, 47 - 48
The transformative journey of chronic myeloid leukemia.
Neelakantan P. and Mead A., (2018), Int J Hematol Oncol, 7
Seronegative antibody-mediated neurology after immune checkpoint inhibitors
Wilson R. et al, (2018), Annals of Clinical and Translational Neurology
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.
Booth CAG. et al, (2018), Cancer cell, 33, 274 - 291.e8
BONE MARROW MYELOPOIESIS INDEPENDENTLY OF CANONICAL NOTCH SIGNALING
Duarte S. et al, (2018), HAEMATOLOGICA, 102, 456 - 456
Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma.
Lee RJ. et al, (2018), Annals of oncology : official journal of the European Society for Medical Oncology, 29, 490 - 496
Incidence and management of immunotherapy-induced colitis in a tertiary melanoma and IBD centre: Clinical practice data
Cheung V. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S198 - S198
Phase 1b/2 study of binimetinib (BINI) in combination with nivolumab (NIVO) or NIVO plus ipilimumab (IPI) in patients (pts) with previously treated microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) with RAS mutation.
Bendell JC. et al, (2018), JOURNAL OF CLINICAL ONCOLOGY, 36
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
Farmery JHR. et al, (2018), Scientific Reports, 8
Canonical Notch signaling is dispensible for adult steady-state and stress myelo-erythropoiesis.
Duarte S. et al, (2018), Blood
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
Woodcock VK. et al, (2018), British Journal of Cancer
Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.
Blagden S. et al, (2018), Wiley interdisciplinary reviews. RNA, 9
ANTI-VCAM-1 TARGETED MRI ALLOWS EARLIER DETECTION OF BRAIN METASTASES IN A XENOGRAFT MELANOMA MOUSE MODEL
Cheng V. et al, (2018), NEURO-ONCOLOGY, 20, 13 - 13
Color Atlas Of Clinical Hematology: Molecular and Cellular Basis of Disease
Hoffbrand AV. et al, (2018), 1 - 585
Genome-scale CRISPR/Cas9 screen identifies factors required for sensitivity to pyrimidine nucleoside analogs
Sarr A. et al, (2018), CANCER RESEARCH, 78
NuTide 302: A phase IB study to assess the safety, pharmacokinetics and clinical activity of NUC-3373 in combination with standard agents used in colorectal cancer treatment.
Blagden SP. et al, (2018), JOURNAL OF CLINICAL ONCOLOGY, 36